Concepedia
Statistics
Publications
18
Citations
1K
H-Index
16
Active since
1994
Affiliations
New Frontier(Current)
Medizinische Hochschule Hannover
Molecular Discovery (United Kingdom)
Mark Tornetta is an author at New Frontier specializing in immunology, antibody engineering, and monoclonal antibodies.
Publications per year
1994–2020
Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models
Robert S. Ames, Dennis Lee, James J. Foley et al. · The Journal of Immunology · 2001 · 201 citations · Full text
Medicine, Immunology, Pharmacology +17
The Human C3a Receptor Is Expressed on Neutrophils and Monocytes, but Not on B or T Lymphocytes
Ulrich Martin, Daniel Bock, Lubomir Arseniev et al. · The Journal of Experimental Medicine · 1997 · 170 citations · Full text
Life Sciences, Immunology, Pathology +17
A T-cell–redirecting bispecific G-protein–coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma
Kodandaram Pillarisetti, Suzanne C. Edavettal, Mark Mendonça et al. · Blood · 2020 · 163 citations · Full text
Medicine, Immunology, Oncology +17
De Novo Selection of High-Affinity Antibodies from Synthetic Fab Libraries Displayed on Phage as pIX Fusion Proteins
Lei Shi, J. C. Wheeler, Raymond W. Sweet et al. · Journal of Molecular Biology · 2010 · 63 citations
Pharmacy, Biotechnology, Molecular Biology +17
The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression
Mark Tornetta, James J. Foley, Henry M. Sarau et al. · The Journal of Immunology · 1997 · 58 citations · Full text
Life Sciences, Immunology, Molecular Biology +15
1–5 of 18